Efficacy and safety of tislelizumab for malignant solid tumor: a systematic review and meta-analysis of phase III randomized trials

Expert Rev Clin Pharmacol. 2023 Oct 21. doi: 10.1080/17512433.2023.2274544. Online ahead of print.NO ABSTRACTPMID:37864420 | DOI:10.1080/17512433.2023.2274544

Source: Expert Review of Clinical Pharmacology - October 21, 2023 Category: Drugs & Pharmacology Authors: Aws Khalid Abushanab Mus'ab Theeb Mustafa Mahmoud Taysir Mousa Rana Ahmed Qawaqzeh Ghaith Nahar Alqudah Renad Fawwaz Albanawi Source Type: research